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Ligands  of  the  TGF-  superfamily  (including  the  TGF-s,  Nodal  and  BMPs)  play  instructive  roles  dur-
ing  embryonic  development.  This  is achieved  by  regulation  of  genes  important  for both  maintaining
pluripotency  and  germ  layer  speciﬁcation  and  differentiation.  Here  we review  how  the  TGF-  super-
family  ligands  signal  to  the  chromatin  to regulate  transcription  during  development.  The effectors  of the
pathway,  the Smad  transcription  factors,  are  regulated  in a  combinatorial  and  spatiotemporal  manner.
This occurs  via  post-translational  modiﬁcations  affecting  stability,  localization  and activity,  as  well as
through  interactions  with  other  transcription  factors  and chromatin  modifying  enzymes,  which  occur
on  DNA.  Expression  proﬁling  and  Chromatin  Immunoprecipitation  have  deﬁned  Smad  target  genes  andmbryonic development binding  sites  on  a genome-wide  scale,  which  vary  between  cell  types  and  differentiation  stages.  This  has
led to  the  insight  that  Smad-mediated  transcriptional  responses  are  inﬂuenced  by the  presence  of master
transcription  factors,  such  as OCT4,  SOX2  and  NANOG  in  embryonic  stem  cells,  interaction  with  other
signal-induced  factors,  as well  as  by the  general  chromatin  remodeling  machinery.  Interplay  with  trans-
criptional  repressors  and  the  polycomb  group  proteins  also  regulates  the  balance  between  expression  of
self-renewal  and  mesendoderm-speciﬁc  genes  in  embryonic  stem  cells  and  during  early  development.©  2014  The  Authors.  Published  by Elsevier  Ltd.  All  rights  reserved.
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. Introduction
Embryonic development occurs by specifying a totipotent cell
nto distinct lineages through the process of differentiation. This
s accompanied by many cellular changes in terms of signaling
athways and epigenetic states. Advances have been made char-
cterizing the chromatin in embryonic systems, including in
arly embryos and embryonic stem cells (ESCs), and we  are
aining an understanding of how signaling pathways inﬂuence
ene expression and execute the correct differentiation-associated
ranscriptional programs. ESCs exist in a state characterized by
heir potential to self-renew, while maintaining the ability to dif-
erentiate along all lineages, and this is achieved by a specialized
ranscriptional network governing their chromatin [1]. Indeed,
SCs and early embryos contain chromatin with speciﬁc charac-
eristics that are different from those deﬁning chromatin of more
pecialized cell types [2]. The TGF- superfamily produces signals
ecessary for both pluripotency and differentiation during early
mbryogenesis, and thus provides a good model to address relay
f extracellular signals to chromatin and molecular mechanisms of
ifferential gene expression. We  will begin with a brief overview
f chromatin and mechanisms regulating gene expression with a
peciﬁc focus on embryonic differentiation. Then, after an intro-
uction to TGF- superfamily signaling in early development, we
ill discuss how the transcriptional effectors of these pathways,
he Smads, act on the chromatin to regulate transcription.
. Chromatin and transcriptional regulation
Genes are transcribed by RNA Polymerase II (Pol II) and this
nvolves initiation, elongation and termination steps, as well as
NA transcript processing [3,4]. Not only is DNA sequence impor-
ant, but the composition of the entire chromatin template is also
nstructive during the transcriptional process. Gene expression is
egulated by transcription factor (TF) binding to either promoters
r distal elements such as enhancers. TFs bind to speciﬁc target sites
n the DNA, and can both positively and negatively regulate tran-
cription via direct control of the general transcription apparatus, or
ndirectly by affecting the chromatin environment through recruit-
ent of chromatin remodeling enzymes [4,5]. Chromatin can be
odiﬁed in various ways, including histone post-translational
odiﬁcation (PTM), nucleosome mobilization and changes to
igher order structure, processes regulated by chromatin mod-
fying enzymes, ATP-dependent nucleosome remodellers and
tructural proteins respectively [5].
Following integration of many genome-wide histone mod-
ﬁcation and factor binding datasets, we can now conﬁdently
istinguish between different cis-regulatory elements, including
romoters, transcribed regions and enhancers (Fig. 1) [6,7]. Inter-
stingly, despite the multitude of possible combinatorial histone
odiﬁcations, only a handful of marks are sufﬁcient to partition the
enome into these various functional domains. Active promoters,
specially those containing unmethylated CpGs, are characterized
y high overall histone acetylation and trimethylation of H3K4,
s well as relative nucleosome depletion and the presence of less
table histone variants including H2A.Z and H3.3 [7]. High his-
one turnover in combination with the neutralization of positive
harge resulting from the acetylation, likely aid in the creation of
ore accessible chromatin [8,9]. In addition, active Pol II is often
ound engaged at promoters producing bidirectional RNA trans-
ripts [10]. Several of the active promoter features are also present
t enhancers, with the exception of trimethylation of H3K4, which
s instead marked by mono-methylation [11]. H3K27Ac and the
resence of the histone acetyltransferase (HAT) p300 are used to
enote enhancer activity [12]. Transcription is often ongoing at
nhancers and much interest has been generated in the role ofevelopmental Biology 32 (2014) 107–118
so-called enhancer-RNAs [11,13]. Repressed, inactive chromatin
is often present in large domains and marked by methylation of
H3K27 and H3K9, which correlates with binding of respectively
Polycomb Group (PcG) proteins and heterochromatin protein 1
(HP1), causing chromatin remodeling and compaction [2,7]. Bound-
aries between the various elements or chromatin states are deﬁned
by the transcriptional repressor CTCF and cohesin binding, and
communication between promoters and enhancers, which can be
located many kilobases apart, is thought to occur through chro-
matin looping [2,7].
TF activity and speciﬁcity are regulated in a combinatorial and
spatiotemporal manner during development, which partly explains
the variety in patterns observed when mapping factor binding dur-
ing stages of differentiation or in different cell types. It is likely
that a combination of DNA sequence, chromatin environment, cel-
lular context and signaling state dictates genome-wide binding
[14]. Cooperative binding occurs between TFs, which can be direct,
through shared co-activators, or operate via an assisted loading
mechanism, where a high on–off rate of one factor on the chromatin
allows another to bind more efﬁciently [15].
It is clear that gene activation occurs in multiple steps, but delin-
eation of the sequence of events occurring on chromatin in response
to differentiation signals remains largely unexplored. As enhancers
act as integration platforms for TF binding and extracellular
signaling pathways, they play important roles in priming genes for
activation [13]. It is likely that binding of most TFs is preceded by
the creation of a favorable environment, including the opening up
of the chromatin through chromatin remodelers or pioneer fac-
tors, for example FoxA1 and MyoD1, which can bind to condensed
chromatin or nucleosomal DNA. This so-called factor relay model
explains how genome-wide, apparently non-functional binding of
one protein precedes, and indeed is required for, the binding of a
signal-inducible transcription factor [6,16]. Differential abilities of
TFs to actively remodel the chromatin are thus important to predict
where on the timescale a factor will act. Alternatively, a balance
may  exist between positive and negative regulators of transcrip-
tion, ensuring enhancers are kept in a poised state [13,17].
Moreover, transcriptional regulation often occurs at the level
of Pol II pause-release, and indeed about one third of all genes
have been found to contain some form of stalled polymerase. Pol
II pausing leads to the creation of open chromatin, facilitates fast,
synchronous gene expression in response to extracellular signals
and reduces transcriptional noise, which is especially important
during development and differentiation. Speciﬁc TFs recruit the
elongation factor pTEFb, which releases proximally-paused Pol II
phosphorylated on Serine 5 from its pausing factors [3,18].
The chromatin in ESCs exists in a generally accessible and trans-
criptionally active state. A speciﬁc characteristic of pluripotent
cells is the presence of so-called bivalent domains, marked by
methylation of both H3K4 and H3K27 (Fig. 1B) [19]. This has been
proposed to maintain an inactive yet ‘poised/primed’ state, and
indeed these modiﬁcations are often found at promoters, and to
lesser extent enhancers, of genes involved in differentiation and
lineage speciﬁcation. The H3K27 methylation is catalyzed by the
PcG proteins [19,20]. During development these bivalent loci are
resolved via histone demethylating enzymes or stable repression.
PcG-repressed regions have additionally been found in more dif-
ferentiated cell types, as well as in zebraﬁsh and mouse embryos
[13,17].
The core regulatory circuitry in ESCs consists of the TFs OCT4,
SOX2 and NANOG (hereafter referred to as OSN). They display over-
lapping genome-wide binding proﬁles and are found at enhancers
of genes both required for pluripotency, while also being bound to
repressed genes important during lineage differentiation, possibly
keeping them in a poised state [1]. OSN additionally regulate their
own  expression, maintaining a robust feedforward loop to ensure
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Fig. 1. Histone modiﬁcations and protein occupancy denote functional elements and transcriptional activity of chromatin. (A) Repressed chromatin is characterized by
methylation of H3K9 and H3K27, linked to HP1 and Polycomb binding respectively, absence of acetylation, CpG promoter methylation and overall nucleosome compaction.
(B)  Poised enhancers and promoters in ESCs represent a bivalent modiﬁcation state, with methylation of H3K4 and H3K27, presence of (paused) RNA Pol II, p300, possible
pioneer  factor binding and PcG proteins, as well as being in an accessible state. (C) Active enhancers are marked by H3K4Me1, H3K27Ac, presence of TFs and p300. Transcription
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wf  eRNAs is shown. (D) Active promoters are characterized by overall high acetylati
oth  S5 and S2 (gene body). H3K36Me3 and H3K79Me further characterize the tran
ull self-renewal potential. The OSN TFs are often co-bound at
nhanceosomes with factors important for the ESC state, including
ther TFs and signaling pathway effectors, as well as certain ESC-
pecialized chromatin modiﬁers. These include p300, components
f the Mediator complex, cohesin/condensin, and speciﬁc nucleo-
ome remodeling complex subunits [1]. Differentiation genes are
aintained in a poised state via recruitment of PcG proteins or the
3K9 methyltransferase SetDB1 [1].
. The function of the TGF- superfamily in development
nd ESCs
TGF- superfamily members play prominent roles in early
ertebrate development to regulate germ layer speciﬁcation, pat-
erning and organogenesis [21]. These pathways differentially
ffect gene expression through interaction with the specialized TF
etwork, cofactors and chromatin environment.
The TGF- superfamily comprises secreted ligands includingGF-s, Activins, Nodal, bone morphogenetic proteins (BMPs),
rowth differentiation factors (GDFs), anti-Mullerian hormone, as
ell as the ligand antagonists Lefty1/2. In the canonical path-
ay, ligand binding to heteromeric complexes of serine/threoninenoted as AcH3) , H3K4Me3 and Pol II released from stalling via phosphorylation of
d region.
kinase receptors leads to their activation and subsequent
phosphorylation of receptor-regulated Smads (R-Smads) [22]. In
general the R-Smads activated by TGF-s, Nodal and Activin are
Smad2/3, while BMP  and GDF ligands signal through Smad1/5/8
[23]. Once phosphorylated, the R-Smads complex with the com-
mon  Smad, Smad4 and are retained in the nucleus where they
regulate transcription of target genes. Finally, the inhibitory Smads,
Smad6/7 are negative feedback regulators of the pathway acting
mainly at the level of receptor degradation [24]. The pathway is
outlined in detail in Fig. 2.
In the mouse embryo, the earliest acting TGF- superfamily
ligand is Nodal which is required for maintaining pluripotency
by regulating expression of Oct4 and Nanog [25]. During gas-
trulation Nodal and BMP  signaling cooperate with Wnt  and
FGF to pattern the cells along distinct lineages (Fig. 3). High
Nodal signaling through Smad2/3 induces deﬁnitive endoderm,
whereas lower levels generate extraembryonic and embryonic
mesoderm [26–28]. BMP4, in addition to inhibiting neurectodermal
differentiation and inducing extraembryonic tissues, cooperates
with Smad2/3-mediated signaling to pattern the primitive streak
toward posterior fates, while actively repressing anterior fates
[28].
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Fig. 2. TGF- superfamily signaling. Overview of the canonical pathway depicting
ligand binding, receptor and Smad phosphorylation, complex formation and nuclear
accumulation. Smads continuously shuttle between cytoplasm and nucleus in the
absence and presence of signal, but Smad complexes are retained in the nucleus
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m23]. The co-receptor CRIPTO is speciﬁcally required for NODAL signaling. Gene
xpression is regulated in concert with cofactors and transcription is terminated
ia dephosphorylation, complex dissociation and Smad nuclear export.Because much of our understanding of how TGF- super-
amily pathways regulate the transcriptional balance between
luripotency and differentiation is based on work performed in
SCs, we will summarize the critical functional ﬁndings here
ig. 3. TGF- superfamily function and interplay during maintenance of ESC pluripotency
elf-renewal versus differentiation, and patterns mesendoderm. Intermediate levels of N
ith  the core transcriptional circuit (OCT4/SOX2/NANOG). LIF and autocrine NODAL signa
eads  to neurectoderm differentiation. Mesendoderm is induced upon high NODAL/ACT
esoderm and deﬁnitive endoderm. BMP  and WNT  signaling antagonize NODAL/ACTIVINevelopmental Biology 32 (2014) 107–118
(Fig. 3). For maintenance of pluripotency, mouse ESCs (mESCs)
require leukemia inhibitory factor (LIF) and BMP  to induce signaling
through Stat3, Erk and Smad1/5, and in addition the cells exhibit
a low level of autocrine Nodal signaling. Human ESCs (hESCs),
which are in fact more similar to mouse epiblast stem cells
(EpiSCs), require FGF and Smad2/3 signaling to maintain pluripo-
tency [29,30]. Despite their different culture requirements, both
mESCs and hESCs differentiate along neurectodermal, mesodermal
and endodermal lineages in a dose-dependent manner in response
to Nodal/Activin signaling (Fig. 3) [26–28]. Nodal/Activin signals
achieve these dose-dependent functions by directly regulating the
OSN TFs, differentiation genes, as well as negative feedback reg-
ulators of the TGF- superfamily pathway like Smad6/7 [31,32].
However, regulation of differentiation genes seems to be dominant,
as inhibition of the pathway more greatly affects these genes rather
than those encoding self-renewal factors [31,33–35]. In hESCs,
PI3Kinase activity induced by various ligands both suppresses WNT
and ERK signaling and reduces levels of activated Smad2/3 in
response to Nodal/Activin, thus promoting self-renewal. In con-
trast, when PI3K activity is low, Nodal/Activin signaling cooperates
with WNT  signaling to promote differentiation [36].
Complex interactions between BMP  and Nodal/Activin signaling
are essential for regulating the self-renewal/differentiation bal-
ance. In mESCs BMP  induces expression of the Id genes, which are
required to maintain pluripotency. However, Nodal can inhibit BMP
signaling in part via Smad7 induction, which feeds back to nega-
tively regulate BMP-induced Smad1/5 signaling [31]. Alternatively,
antagonism between BMP  and Nodal/Activin can be achieved by
direct competition for Smad4 [37]. In hESCs BMP-induced differ-
entiation must be inhibited by Nodal/Activin signaling speciﬁcally
through Smad2 to maintain NANOG and OCT4 expression and to
keep the cells in a pluripotent state [38].
4. Regulation of TGF- superfamily/Smad-mediated
transcription
4.1. Post-translational modiﬁcations of Smads
The R-Smads and Smad4 have two conserved domains,
the N-terminal Mad  homology (MH) 1 and C-terminal MH2
domains, separated by a less well-conserved serine and proline-
rich linker region. The MH1  domain is primarily involved in
DNA binding and nuclear import, whereas the MH2  domain is
 and germ layer differentiation. Graded NODAL/ACTIVIN signaling determines ESC
ODAL and BMP, which counteract each other, maintain self-renewal via interplay
ling (red arrow) is essential in mESCs. In the absence of NODAL/BMP, FGF signaling
IVIN signaling in collaboration with WNT  and FGF, and is further patterned into
 signaling and promote posterior mesoderm fates.
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aig. 4. Post-translational modiﬁcations of the Smads. Modiﬁcations of the R-Smad
ites  are for Drosophila Smad4, Medea. In the R-Smad linkers only the MAPK/CDK
biquitination; Ac, acetylation; P, phosphorylation; PAR, PARylation.
equired for receptor-mediated Smad C-terminal phosphoryla-
ion, Smad–Smad interaction and is the site for binding of many
ifferent transcriptional regulators [39]. The Smads are subject
o numerous post-translational modiﬁcations that regulate their
ctivity or allow other signaling pathways to inﬂuence TGF-
uperfamily signaling [39] (Fig. 4). We  will here focus on the
odiﬁcations that most critically affect Smad transcriptional activ-
ty.
The most intensively researched modiﬁcation is phosphoryla-
ion of conserved Ser/Thr-Pro motifs present in all the R-Smad
inkers, executed by both MAP  kinases (MAPKs) and cyclin-
ependent kinases (CDKs) [40–44]. Linker phosphorylation was
riginally thought to limit the activity of the Smads in the nucleus
42,43], and/or to limit the duration of TGF- superfamily sig-
als [41,44]. Phosphorylation of these linker Ser/Thr residues in
mad1/5 by MAPKs, and subsequent phosphorylation by GSK3, was
hown to lead to degradation of activated Smad1/5 [41,44]. The E3
biquitin ligase responsible is Smurf1, which binds Smad1 through
ts WW domain when the linker is phosphorylated (Fig. 4) [44].
he E3 ubiquitin ligase NEDD4L is thought to play a similar role
or Smad2/3 [45]. More recently, it has been suggested that linker
hosphorylation not only downregulates BMP/TGF- signaling, but
ight initially be required for transcriptional activity. R-Smads
ngaged in transcription can be phosphorylated on chromatin at
he linker Ser/Thr-Pro sites by CDK8/9. This leads to transcriptional
ctivation via interaction with WW-containing cofactors like YAP
n the case of Smad1/5, or Pin1 in the case of Smad2/3, before being
dditionally phosphorylated by GSK3 and degraded as described
bove [40,46]. Smad4, with an indication as to their function. In Smad4 the lower sumoylation
phorylation sites are shown. For further details see text. Sumo, sumoylation; Ub,
Linker phosphorylation does not always lead to degradation.
In the early zebraﬁsh embryo, Smad1/5 linker phosphorylation
leads to a localized reduction in BMP  activity in the absence
of Smad1/5 degradation [47]. In a very recent study in hESCs,
Smad2/3 linker phosphorylation by CDK4/6-cyclin D complexes
was reported to control Smad2/3 transcriptional activity by pre-
venting Activin-induced nuclear accumulation [48]. As a result,
only cells in the early G1 phase (where cyclin D levels are low)
are sufﬁciently responsive to Activin to differentiate into mesendo-
derm, whereas compromised Smad2/3 activity at other phases of
the cell cycle leads to differentiation to neurectoderm. Some of the
controversy surrounding the function of the linker phosphoryla-
tion may  arise from the fact that phosphorylation of various linker
sites has different effects. This has been highlighted in a study of
the phosphorylation of T179 in Smad3 (Fig. 4), which promotes
Smurf2 binding. The consequent monoubiquitination at two lysines
in the MH2  domain disrupts Smad3–Smad4 complexes, decreasing
Smad3 nuclear accumulation and TGF- transcriptional responses
[49].
The regulation of complex formation by monoubiquitination has
also been shown for Smad4 [50,51] (Fig. 4). In this case, the ubiquit-
ination is catalyzed by TIF1 (also called TRIM33 and Ectodermin),
which is activated by binding to chromatin, recognizing combinato-
rial histone modiﬁcations via its PHD ﬁnger-bromodomain [50,52].
Smad4 monoubiquitination speciﬁcally disrupts chromatin-bound
Smad complexes and thus TIF1 is responsible for dictating the
residence time of Smad complexes at TGF- superfamily-regulated
enhancers [50]. Smad4 ubiquitination is reversed in the cytoplasm
by the deubiquitinase, FAM/USP9x [51].
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Smad3 and Smad4 DNA binding activity is additionally regulated
y ADP-ribosylation (PARylation), which is induced by poly(ADP-
ibose) polymerase-1 (PARP-1) [53]. In Smad3, PARylation of two
lutamic acid residues in the MH1  domain is thought to lower
NA binding afﬁnity of the Smad3–Smad4 complex, leading to
educed transcriptional activity [53]. How Smad PARylation is reg-
lated is not yet known. Sumoylation and acetylation of the Smads
as also been demonstrated. Lysine acetylation in the Smad2/3
H1  domains promotes transcriptional activity, whilst sumoyla-
ion of Smad4 on a site in the MH1  domain and one in the linker
as mostly been shown to repress it. However in some assays
mad4 sumoylation has been associated with increased transcrip-
ional activity (reviewed in [54]). Interestingly, in the context of
rosophila Smad4, Medea, sumoylation promotes nuclear export
nd thus increased BMP  responses are observed in SUMO pathway
utant embryos [55].
.2. Recruitment of activated Smad complexes to DNA
All R-Smads except Smad2 bind DNA directly, as does Smad4
39,56]. The preferred binding site of the Smad3 and Smad4 MH1
omains was deﬁned as the short motif, GTCT [57], which is com-
only referred to as a Smad binding element (SBE). Direct or
nverted SBE repeats have been mapped in enhancers of many
GF--induced target genes, and are required for TGF-/Smad-
egulated transcription [39].
Pioneering work in Drosophila revealed that the MH1  domain
f Mad  (Drosophila Smad1/5) has a different DNA-binding speci-
city and recognizes a GRCGNC motif, with two Mad  MH1  domains
inding the motif [58]. Despite sequence similarity between dif-
erent R-Smads, the DNA contact interface of Smad1 is structurally
earranged compared with that of Smad3 [59]. In DPP-responsive
nhancers (where DPP (Decepentaplegic) is a Drosophila BMP
igand), this motif is found in conjunction with either a canonical
mad3/4 binding site (GTCT) or a GNCV motif, also thought to bind
mad4. In both cases these sites are separated by 5 nucleotides
60,61]. Both the GRCGNC(N5)GTCT and the GRCGNC(N5)GNCV
otifs bind complexes of Mad  and Medea (Drosophila Smad4).
owever, the former sites additionally bind the zinc ﬁnger tran-
cription repressor Schnurri and as a result, act as silencer
lements; the latter do not bind Schnurri and act as activatory
lements [60,61]. The spacing of ﬁve nucleotides between these
lements is crucial for Schnurri binding [60]. There is an additional
ayer of regulation of these elements in Drosophila as a subset of
he GRCGNC motifs, those that have the sequence GGCGYY, bind
he transcriptional repressor Brinker [61]. Brinker represses these
lements in the absence of a BMP  signal, and Brinker itself is trans-
riptionally repressed in response to DPP. For some genes, such as
ptomoter-blind, loss of Brinker binding is sufﬁcient for activation.
n other cases, such as the spalt major gene, activated Mad/Medea
omplexes bind to the sites exposed by loss of Brinker and this
s required for full activation [62]. Similar GRCGNC(N5)GTCT and
RCGNC(N5)GNCV motifs have been mapped in vertebrate BMP-
esponsive genes such as the Id genes and ventx2 and shown to
e crucial for BMP  regulation [63]. As in Drosophila,  the spac-
ng of 5 nucleotides between the elements is critical, suggesting
hat a mammalian Schnurri (of which 3 are known) may  also be
equired [63–65]. Intriguingly, no Brinker has been identiﬁed in
ertebrates to date. However, the fact that many conserved ver-
ebrate Smad1/5-binding sites are also Brinker consensus sites
uggests that a vertebrate Brinker might exist.
The afﬁnity of Smads for DNA is weak (Kd ≈ 1 × 10−7 M),  and
hus high afﬁnity and high speciﬁcity recruitment of Smads to
NA frequently requires additional DNA-binding proteins. The
rst identiﬁed was FoxH1 (originally called FAST-1), which was
hown to recruit an activated Smad2–Smad4 complex to an Activinevelopmental Biology 32 (2014) 107–118
responsive element in the Xenopus Mix.2 gene [66,67]. Binding
sites for FoxH1–Smad complexes have subsequently been found
in numerous mouse genes active during embryonic development
[68], as well as in Nodal-responsive genes in ﬁsh and human [69,70].
In Xenopus, homeodomain proteins of the Mix  family (Mixer, Bix2
and Bix3) recruit activated Smad2–Smad4 complexes to DNA via
a Smad binding motif that is also present in FoxH1 [71,72]. Fur-
thermore, in zebraﬁsh loss of both FoxH1 (sur) and Mixer (bon)
results in a phenotype consistent with a severe reduction of Nodal
activity [73]. Complete loss of Nodal signaling in zebraﬁsh how-
ever results in a more severe phenotype, suggesting additional
Smad2-recruiting TFs exist. Indeed, numerous other transcription
factors and chromatin remodeling factors have been shown to
interact with the activated R-Smad–Smad4 complexes and will be
addressed in detail below, where we focus on regulation of Smad
target genes during development [39,74].
4.3. Speciﬁcity and diversity dictated by various cofactors
In response to TGF- superfamily signaling, Smad binding
to chromatin is not always sufﬁcient for a full transcriptional
response and requires additional steps to generate context-speciﬁc
target gene selectivity. This is especially important during devel-
opment where Nodal/Activin regulates both self-renewal and
differentiation-speciﬁc genes, and indeed these genes display
differential sensitivity to manipulation of the pathway [75,76].
Genome-wide analyses (including Chromatin Immunoprecipitat-
ion (ChIP) and expression arrays) examining both chromatin
context and DNA sequence have identiﬁed multiple cofactors
important for generating the differential Smad transcriptional
response [34,76–86].
4.3.1. Repressors
Chromatin is kept in a transcriptionally inactive state through
recruitment of histone deacetylase (HDAC) enzymes and corepres-
sors, and often contains repressive H3 methylations on K9 and
K27. For example, mesendodermal Smad2/3 target genes includ-
ing Brachyury,  Mixl1 and Eomes,  are kept inactive in ESCs by
transcriptional repressors, as outlined in Fig. 5A. Zeb-1/EF1 and
SIP1/Zeb-2 are two  related ZF proteins, which repress transcription
through recruitment of CtBP corepressors. Both bind in a sequence-
speciﬁc manner to DNA and are able to interact with R-Smads
[87,88]. Interestingly, while Zeb-1/EF1 was  found to switch to a
transcriptional activator through Smad-mediated p300 and P/CAF
recruitment, SIP1/Zeb-2 lacks the lysine residues targeted by p300
and therefore dominantly represses transcription of Smad target
genes [87,88]. In hESCs, Smad2/3 along with OCT4 and NANOG
control the expression of Zeb-2/SIP1 [89]. Upon Activin-induced
mesendoderm differentiation, expression of Zeb-2/SIP1 is down-
regulated. Conversely, loss of signaling causes SOX2-mediated
enhanced expression of Zeb-2/SIP1. This allows SIP1 to fully repress
Smad2/3 target genes including pluripotency genes in the absence
of signaling, leading to neurectodermal differentiation. In contrast,
high Nodal/Activin signaling attenuates the repression of mesendo-
dermal genes [89].
SNON and the highly related protein SKI repress transcription
via recruitment of corepressors such as N-CoR and/or mSin3A, and
keep TGF-/Nodal/Activin target genes repressed in the absence
of a signal via binding to SBEs with Smad4 [90] (Fig. 5A). Upon
TGF-/Nodal/Activin signaling, as occurs during mesendodermal
differentiation, SNON and SKI are rapidly degraded by the pro-
teasome in a process that is dependent on the E3 ubiquitin
ligase Arkadia [91–94]. This exposes the SBEs, allowing activated
Smad3–Smad4 complexes to bind and transcription to be activated.
In hESCs SNON is highly expressed and primarily associated with
differentiation genes, and is lost upon differentiation [94].
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Fig. 5. Collaboration with Smad transcription factors on the chromatin. (A) Mechanisms of gene repression of Smad target genes, and their subsequent activation upon
elevated NODAL/ACTIVIN signaling. (I) SIP1/ZEB-2 mediates Smad target gene repression via recruitment of CtBP, but is transcriptionally inhibited by Smads in collaboration
with  NANOG and OCT4. (II) SNON recruits corepressors NCoR and mSIN3A, yet is ubiquitinated and degraded by ARKADIA upon TGF-/ACTIVIN/NODAL signaling. (III)
TIF1/TRIM33 both inhibits and activates Smad-mediated transcription, in the latter case through binding to H3K9Me3. (IV) JMJD3 demethylates PcG-induced repressive
H3K27Me3 marks and collaborates with Smads in transcription. (B) Interactions with signal-induced transcription factors of the WNT  and HIPPO pathway, as well as OSN TFs
during  ESC maintenance and differentiation. Induction of EOMES leads to a self-enabling response where EOMES will co-activate further mesendoderm genes together with
Smad2/3. (C) Use of the general transcription machinery and nucleosome remodelers in Smad-mediated transcriptional responses. Pioneer factor binding leads to BRG1-
mediated chromatin remodeling, which in turn allows Smad binding. Smads have also been shown to recruit BRG1, along with p300 and Arc105, leading to enhancer–promoter
looping and transcription.
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Another mechanism regarding Smad2/3 binding to repressed
enes is via the action of the above-mentioned TRIM33/TIF1
Fig. 5A) [52,95]. This E3 ubiquitin ligase has been shown to form
on-canonical complexes with phosphorylated Smad2/3, and to
peciﬁcally bind in the upstream regions of the mesendoderm
enes Gsc and Mixl1. It recognizes H3 tails unmethylated on K4, but
ontaining K9 methylation as well as acetylation on other lysines.
his displaces HP1, and further chromatin remodeling via an as yet
nidentiﬁed mechanism, allows canonical Smad2/3–Smad4 com-
lexes to bind their target enhancer sites to induce activation of Gsc
nd Mixl1 during ESC differentiation [52,95].
Finally, it must be noted that in addition to this maintenance
f Smad target genes in an inactive state, Smads can also actively
epress transcription via recruitment of repressors, examples of
hich include ATF3 and Schnurri [63,65,96].
.3.2. Regulation of bivalent and poised genes via H3K27
emethylation
PcG proteins achieve transcriptional repression via H3K27
ethylation, which can be reversed by demethylating enzymes
uch as JMJD3 and UTX [97]. PcG proteins are essential for proper
SC differentiation, and an intact PcG system is required for
mad2/3-controlled genes in ESCs exiting from the ground state
17,33,98]. A model is emerging where Nodal/Activin signaling
ooperates with other factors in maintaining pluripotency and
irecting differentiation, speciﬁcally via removal of repressive
3K27 methylation marks.
Smads likely direct JMJD3 to target genes in ESCs and during
ifferentiation via direct interaction (Fig. 5A). Bivalent domains
re resolved during hESC differentiation into endoderm, and con-
equently most Nodal targets lose their repressive H3K27 mark
uring deﬁnitive endoderm formation [98]. Smads are thought to
nduce a transient recruitment of JMJD3 to these promoters, as
or example, Nodal and Brachyury expression in response to Nodal
ignaling coincides with loss of H3K27 methylation [98,99]. Neu-
al stem cells undergo differentiation in response to TGF-, for
hich an interaction between Smad3 and JMJD3 is required, and the
wo proteins have been found to co-bind and co-regulate a subset
f TGF- target genes [100]. BMP-responsive Smads also require
MJD3 for transcriptional activation of Noggin during neural tube
evelopment [101].
However, contrasting evidence exists with regard to the
equence of events occurring at the chromatin in these mod-
ls. Despite observing JMJD3 occupancy and an effect on gene
xpression, a change in H3K27Me3 state is not always detected.
urthermore either Smad or JMJD3 binding can be transient or per-
istent depending on the system used. Moreover, only a subset of
GF- targets is affected by JMJD3, including up-and downregu-
ated, and differentiation/self-renewal genes [98–100].
.3.3. Signal crosstalk at the level of transcription factor binding
Smads regulate target genes during development in collab-
ration with other sequence-speciﬁc TFs, which can be either
onstitutively nuclear (such as Nanog, FoxH1 and Eomes), or
re responsive to extracellular signaling, and thus form another
latform for integration of the TGF- superfamily with other
athways (Fig. 5B). Examples include interactions with effectors
f Wnt  signaling, for instance upon transcriptional activation of
rachyury during mesoderm induction (Smad2/3 and -catenin),
r graded Msx1/2 expression mediated via Smad1–Smad4–Lef1
omplexes [99,102,103]. In addition, much interest has been gen-
rated recently in the role of Hippo pathway signaling in stem
ell self-renewal and proliferation. The transcriptional coactivators
AP/TAZ dominantly function to localize activated Smad complexes
o either the cytoplasm or nucleus, and in addition stimulate Smad
ranscriptional activity on target genes [46,104]. Indeed, TAZ hasevelopmental Biology 32 (2014) 107–118
been shown to be essential for mediating Activin/Smad2-induced
self-renewal of hESCs [104] and YAP has been reported to interact
with activated Smad1 [40,46].
4.3.4. Use of the basal transcription machinery
One interesting aspect regarding signal-responsive transcrip-
tion factors such as the Smads is how they make use of the basal
transcription machinery and therefore provide target gene speci-
ﬁcity to otherwise general factors in a context-dependent manner
(Fig. 5C). Examples include the well-studied recruitment of the
HATs p300 and CBP to mediate gene activation [74,105,106]. In
addition, communication with Pol II may  be mediated via inter-
actions with Arc105, a component of the Mediator complex, as
overexpression or knockdown of Arc105 in Xenopus embryos
exactly phenocopies gain and loss of Nodal signaling respectively
[107]. Evidence also exists for the requirement of SWI/SNF nucleo-
some remodeling component BRG1 to be recruited by Smad2/3 in
response to TGF- signaling [74,108]. BRG1 is essential in ESCs,
and regulates many pluripotency and early differentiation genes.
As part of the ESC-speciﬁc esBAF complex, it interacts with the
OSN TFs, as well as with Stat3/Smad1 downstream of LIF and
BMP  signaling pathways in mESCs [109,110]. BRG1 creates a favor-
able chromatin environment for TFs to bind, but is also able to
mediate gene repression and thus facilitates OSN-mediated gene
poising [111]. Knockdown of BRG1 abrogates a subset of TGF--
induced gene expression changes, indicating that BRG1-mediated
chromatin remodeling is an essential mechanism for transcriptio-
nal regulation for at least a subset of Smad2/3 target genes [108].
BPTF is another nucleosome remodeler, this time of the ISWI fam-
ily, found to interact with Smads and to mediate Nodal-induced
extraembryonic endoderm differentiation in early mouse embryos
[112]. It remains unclear whether TGF- superfamily signaling
leads to active nucleosome depletion, or indeed whether this is a
prerequisite for the Smads to ﬁnd their DNA binding elements.
4.4. Genome-wide chromatin occupancy and gene
expression—what we have learned to date
Genome-wide investigation of Smad targets at both the DNA
occupancy and gene expression level has revealed cell-type speciﬁc
and dose-dependent differences in the transcriptional responses.
Furthermore, ChIP-seq has now proven that most Smad binding
events occur at distal elements such as enhancers. In cases where
chromatin binding was  correlated with expression data, it is also
clear that many Smad-bound sites are not necessarily near a gene
whose transcription changes [76,98].
The ﬁrst studies examining Smad2/3 and Smad4 chromatin
occupancy made use of promoter arrays, and as well as identifying
known and novel target genes with differential response patterns to
TGF- superfamily signaling, noted the co-occurrence of DNA bind-
ing sites for ERK-responsive transcription factors, including AP1,
TFAP2a, E2F, ELK1, ETS1 and JUN [79–81,85]. Indeed, manipulation
of several of these TFs leads to an altered response of a subset of
TGF- target genes, although the interaction can be both activat-
ing or repressing depending on the gene and context. Furthermore,
detailed sequence analysis has in the case of Smad1/5 further
reﬁned the GC-rich BMP-responsive DNA element and shown that
differential afﬁnity for certain sites is in part dictated by DNA
sequence [83].
Comparison of Smad genome-binding patterns has subse-
quently addressed cell-type speciﬁc differences, and for instance
revealed that HNF4  is speciﬁcally required for a differential
Smad2/3 distribution in hepatocytes compared to keratinocytes
[82]. Indeed, Smads appear to share many overlapping targets with
cell-type speciﬁc transcription factors especially important for cell
identity. In both human and murine ESCs, Smad2/3 have been found
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o co-occupy regions with the OSN TFs, possibly via creation of a
avorable chromatin environment at the OSN binding sites, which
llows the Smad proteins to bind in response to signaling, in line
ith the pioneer factor model of transcriptional regulation [84].
mad1 presence was also detected at enhanceosomes in mESCs,
ollaborating with the OSN TFs and Stat3 to regulate both pluripo-
ency and early differentiation genes [113]. As some of the OSN and
mad2/3 co-occupied sites additionally bind FoxH1, it is not clear
hether the pluripotency factors directly recruit the Smads to DNA.
s has very recently been demonstrated in zebraﬁsh, OSN may  be
equired for priming genes for future activation, which is medi-
ted by tissue-speciﬁc or signal-induced transcription factors, in
his case FoxH1–Smad complexes, bound in the vicinity [114,115].
Moreover, in more differentiated cell types the TFs responsi-
le for maintaining cell identity, such as PU.1 in B-cells, Gata1/2 in
rythroid progenitors, C/EBP  in myeloid progenitors and MyoD1
n myotubes, have been found to co-bind many sites with Smads
84,86]. In a few cases, the authors addressed the hierarchy of
ecruitment and found that distribution of the master TFs is largely
naffected by changes in TGF- superfamily signaling, and instead
ictates Smad binding at those target sites. However, it is important
o note that the master TFs appear to have a much larger number of
arget sites than the Smad proteins, and not all binding events lead
o gene expression changes. Finally, the actual biological signiﬁ-
ance of Smad–master-TF cooperation in each cell type has not been
ully addressed. An example is the co-binding of Smad3 with MyoD
n myotubes, as it has been shown that TGF- in fact inhibits mus-
le differentiation by interfering with MyoD target gene activation
116].
. Perspectives and outstanding questions
Smads display a highly dynamic binding pattern during devel-
pment, as has been shown by the shifting of binding sites upon
ifferentiation of hESCs into deﬁnitive endoderm [77,98,117].
verlay of these targets with other TFs or chromatin marks con-
rms the association of Smads mainly with enhancers, as well as
inding to both expressed and poised genes. This latter type high-
ights the requirement of an additional event, including binding of
he correct cofactor (such as the TF EOMES), removal of an inhibitor
such as SNON) or remodeling of the chromatin environment (such
s H3K27 demethylation) [77,98,117]. Important open questions
emain as to what deﬁnes target gene selectivity for most of these
actors, to what extent they are a cause or consequence of Smad
hromatin binding, how direct the interaction is and where they
ct in the transcriptional sequence of events. With the identiﬁca-
ion of the variety of Smad binding partners it will be interesting to
ddress to what extent modiﬁcation of the Smads directly impacts
heir transcriptional activity. Studies on linker phosphorylation,
biquitination and PARylation show that regulation can occur in
erms of nuclear versus cytoplasmic localization, protein stability,
mad complex formation and chromatin residence time.
Since only a subset of binding sites or target genes are affected by
ach identiﬁed cofactor, it will be important to determine whether
ubclasses of genes require different modes of transcriptional reg-
lation. For instance, Smads regulate ‘housekeeping’ type genes,
hich include some negative feedback regulators that may  be in a
onstitutive open chromatin state with Smads only ﬁne-tuning out-
ut levels. Alternatively, differentiation genes are often maintained
n a poised state, and active chromatin remodeling processes must
ake place to enable transcriptional responses [95]. Thus, while
he pioneer factor hypothesis provides an explanation for recruit-
ent of Smads to different target loci in different cell types, Smads
ay  also play an instructive role themselves in targeting subse-
uent factors during regulation of the transcriptional sequence ofevelopmental Biology 32 (2014) 107–118 115
events. Examples exist for Smads directing the binding of secondary
transcriptional regulators, such as Smad3 redistributing the nuclear
Vitamin D receptor during TGF--induced liver ﬁbrotic response,
which in turn antagonizes Smad binding to attenuate target gene
upregulation, demonstrating an elegant model of negative feedback
at the genomic level [118]. A self-enabling type response may  also
be required for some genes, where ligand-dependent production
of a cofactor is necessary for cooperative activation of a previously
bound Smad target. For instance, during mesendoderm differen-
tiation of ESCs, Smad2/3 regulate expression of OCT4 and NANOG,
and have also been shown to collaborate with NANOG at a subset of
genomic regions. NANOG restricts Smad2/3 transcriptional activity
during self-renewal and the earliest mesendoderm differentiation
steps. Together they regulate the expression of the ﬁrst mesendo-
derm regulators including EOMES. Furthermore, EOMES  itself can
co-regulate expression of endoderm-speciﬁc genes together with
the Smads (Fig. 5B) [32,77,117,119]. Thus, during sequential stages
of development Smads regulate expression of lineage regulators,
and actively associate with these factors to further specify differ-
entiation. This is an elegant illustration of the factor relay model
mentioned in Section 2.
While not all genome-wide studies interrogating Smad bind-
ing have addressed their distribution over differentially annotated
genomic sites (partly limited by the use of promoter regions
speciﬁcally in the earlier ChIP-Chip studies), some contrasting evi-
dence exists as to whether Smads preferentially regulate genes
via promoter or enhancer binding. Localization to distal elements
is undisputed, as has been shown by overlay of Smad peaks
with DNase hypersensitivity data and histone modiﬁcation marks
indicative of enhancers. In several cases a dynamic shift in genomic
binding sites was  observed upon signal manipulation, with higher
signaling leading to preferential distal occupancy [76,98]. It can
be argued that peaks observed around the transcriptional start
sites of target genes are secondary events detected via crosslink-
ing of looped chromatin. Either way, this requires communication
between enhancer and promoter regions, which is proposed to be
essential in the recruitment of the general transcription machin-
ery. It will be interesting to address to what extent Smad proteins
directly regulate Pol II, at the level of either de novo recruitment or
pause-release. One could envision that this is related to gene induc-
tion dynamics, as developmentally important genes often respond
with fast kinetics during differentiation.
An outstanding question regarding Nodal/Activin signaling in
ESCs is their ability to both maintain pluripotency and induce differ-
entiation. Many ChIPs are carried out under steady state signaling
conditions or in untreated ESCs, with only few studies addressing
to what extent timing and dose of Smad activation affect gene
expression responses. It will therefore be important to investi-
gate whether subsets of Smad target genes respond in different
ways to different intensities of signal. This partitioning may  be
related to previously reported existence of ‘synexpression groups’
[120,121], where Smads regulate different groups of target genes
in different manners via speciﬁc cofactors, and perhaps also modes
of chromatin remodeling and Pol II regulation. Indeed, evidence
for this is accumulating as different cofactors show speciﬁcity for
either pluripotency or differentiation genes. It is intriguing that
the same TFs can both activate and repress transcription. Knock-
down of known chromatin remodelers interacting with Smad2/3,
such as JMJD3 or BRG1, affect both up-and down-regulated genes
[100,108], suggesting their target gene subset speciﬁcity is not
dependent on their function as general activators. To understand
how extracellular signals impact gene expression, we  must delin-
eate the sequence of events occurring on the chromatin, starting
with the recognition and accessibility of different Smad bind-
ing sites, leading to collaboration with both sequence-speciﬁc TFs
and general chromatin remodeling and transcription machinery to
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enerate the appropriate response, both in terms of amplitude and
uration.
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